Why the study?
Long QT syndrome dramatically increases the risk of fatal cardiac events during the 9 months after delivery, necessitating summarized guidance on management during pregnancy and beyond.
What is the recommended management for women with Long QT Syndrome during pregnancy and the postpartum period?
What is the recommended management for women with Long QT Syndrome during pregnancy and the postpartum period?
Answers are grounded in this paper and cite their sources.
Women with Long QT Syndrome require continuous beta-blocker therapy throughout pregnancy and the high-risk 9-month postpartum period to prevent fatal arrhythmias.
Long QT syndrome (LQTS) is majorly an autosomal dominantly inherited electrical dysfunction, but there are exceptions (Jervell and Lange-Nielsen syndrome is inherited in an autosomal recessive pattern). This disorder prolongs ventricular repolarization and increases the risk of ventricular arrhythmias, syncope, and even sudden cardiac death. The risk of fatal events is reduced during pregnancy, but dramatically increases during the 9 months after delivery, especially in patients with LQT2. In women with LQTS, treatment with β-blockers at appropriate doses is recommended throughout pregnancy and the high-risk postnatal period. In this review, we summarize the management of LQTS during pregnancy and beyond.
No takes yet. Share an insight, caveat, or question.
Marcinkeviciene et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: